申请人:Sandoz, Inc.
公开号:US04397850A1
公开(公告)日:1983-08-09
This disclosure describes compounds of the formula ##STR1## where R.sub.1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms or lower alkoxy having 1 to 4 carbon atoms, and R.sub.2 represents hydroxy, and R.sub.3 and R.sub.4 each independently represent lower alkyl as defined above, or R.sub.3 and R.sub.4 together with N represent ##STR2## wherein n is 1, 2, or 3, and R.sub.5 and R.sub.6 each independently represent hydrogen or lower alkyl as defined above, and R.sub.7 represents lower alkyl as defined above, or a pharmaceutically acceptable acid addition salt thereof, which are useful as anti-diabetic agents, in particular as hypoglycemic agents and inhibiting or impeding postprandial hyperglycemia.
本公开说明了化合物的结构式为##STR1##其中R.sub.1代表氢、氟、氯、具有1到4个碳原子的低烷基或具有1到4个碳原子的低烷氧基,R.sub.2代表羟基,R.sub.3和R.sub.4独立地代表如上所定义的低烷基,或R.sub.3和R.sub.4与N一起代表##STR2##其中n为1、2或3,R.sub.5和R.sub.6各自独立地代表氢或如上所定义的低烷基,R.sub.7代表如上所定义的低烷基,或其药学上可接受的酸加合盐,其用作抗糖尿病剂,特别是作为降血糖剂和抑制或阻碍餐后高血糖的药物。